Global and Community Health

Asian Liver Center’s community research aims to provide evidence based information that would be of value to policy makers in developing effective national strategies to prevent chronic hepatitis B and liver cancer. For more, see Recent Publications.

2018

Toy M, Hutton DW, So S. (2018) Population health and economic impacts of reaching chronic hepatitis B diagnosis and treatment targets in the US. Health Affairs 37(7):1033-1040.

Ispas S, So S, Toy M. Barriers to Disease Monitoring and Liver Cancer Surveillance Among Patients with Chronic Hepatitis B in the United States. J Community Health. 2018 Dec 11. doi: 10.1007/s10900-018-00604-7. [Epub ahead of print]

Han SS, Kelly SP, Li Y, Yang B, Nguyen M, So S, Rosenberg PS, Hsing AW. Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States. J Natl Cancer Inst. 2018 Dec 13. doi: 10.1093/jnci/djy180. [Epub ahead of print]

Toy M, Wei B, Virdi TS, Le A, Trinh H, Li J, Zhang J, Hsing AW, So SK, Nguyen MH. Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California. Hepatol Med Policy. 2018 Jun 5;3:6. doi: 10.1186/s41124-018-0034-7. eCollection 2018.

Yang B, Liu JB, So SK, Han SS, Wang SS, Hertz A, Shariff-Marco S, Lin Gomez S, Rosenberg PS, Nguyen MH, Hsing AW. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention. Cancer. 2018 Sep 1;124(17):3551-3559. doi: 10.1002/cncr.31598. Epub 2018 Aug 16.

 

2017

Fitzmaurice C, Allen C, Barber RM et al. (2017) Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study JAMA Oncology 2017; 3 (4): 524-548. 10.1001/jamaoncol.2016.5688.

A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report. Gillian J. Buckley and Brian L. Strom, Editors; Committee on a National Strategy for the Elimination of Hepatitis B and C; Board on Population Health and Public Health Practice; Health and Medicine Division; National Academies of Sciences, Engineering and Medicine. Washington, DC. 2017.

 

2016

National Academies of Sciences, Engineering and Medicine. 2016. Eliminating the public health problem of hepatitis B and C in the United States: Phase one report. Washington, DC: The National Academies Press. doi:10.17226/23407.

Wang J, Feng Q, Tam A, Sun T, Zhou P, So S. 2016. Evaluation of the first open-access hepatitis B and safe injection online training course for health professionals in China. BMC Med Educ. Mar 8;16:81. doi: 10.1186/s12909-016-0608-2.

Stanaway JD, Flaxman AD, Naghavi M et al. 2016. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet 388(10049): 1081-1088. doi: 10.1016/S0140-6736(16)30579-7. Epub 2016 Jul 7.

  •